▎Ovagen Research
What is the research background of Crystagen?
The research background of Crystagen primarily stems from deeper investigations into immune system regulation and aging-related biological processes. With advancing age, the balance of protein synthesis and function within the body is disrupted, leading to the onset of various diseases. As a short-chain peptide bio-modulator, Crystagen's sequence—composed of glutamic acid (Glu), aspartic acid (Asp), and proline (Pro)—activates gene expression by complementarily binding to specific DNA sites. This promotes protein synthesis, thereby sustaining physiological functions. This mechanism provides a theoretical foundation for delaying aging and enhancing immune function.
What is Crystagen's mechanism of action?
Activation of B cells in the immune system
Direct activation of B cells: Crystagen activates B cells within the immune system. B cells primarily produce antibodies and participate in humoral immune responses. When pathogens invade the body, B cells recognize antigens and become activated through a series of signaling pathways. They then differentiate into plasma cells that secrete specific antibodies to eliminate pathogens. Crystagen may activate B cells by binding to specific receptors on their surface, triggering intracellular signaling pathways. This enhances B cells' ability to recognize antigens and initiate immune responses[1].
What are the applications of Crystagen?
In immune modulation, Crystagen significantly enhances the body's immune function, making it beneficial for treating various immune-related diseases. It can be used to treat acute or chronic inflammation, including respiratory tract infections (such as pharyngitis, bronchitis, sinusitis, pneumonia, etc.), urinary tract infections (such as cystitis, pyelonephritis), prostatitis, and adnexitis. Crystagen also demonstrates positive effects in treating autoimmune diseases and systemic connective tissue disorders, offering new therapeutic options for these conditions.
In postoperative and rehabilitation settings, Crystagen can be applied during various surgical procedures before and after operations to aid patients in restoring physical strength and immune function. For patients recovering from heart attacks or strokes, Crystagen promotes bodily recovery and reduces the incidence of complications. Its application in elderly patients and immunocompromised individuals is also gaining significant attention. It helps maintain immune function in the elderly and improves age-related immune decline. For patients affected by adverse factors such as infections, radiation, chemotherapy, emotional stress, environmental factors, climatic conditions, endemic diseases, and ionizing radiation, Crystagen exerts positive regulatory effects, enhancing the body's disease resistance.
Crystagen also demonstrates potential in tumor prevention. By modulating immune system function, it may help reduce the risk of tumor development. Additionally, Crystagen can be employed in the treatment of chronic poisoning, aiding in the recovery of poisoned patients.
Conclusion
As a synthetic peptide-based biological modulator, Crystagen exhibits immunomodulatory effects, enhancing immune function and improving immune deficiency states caused by various factors. It demonstrates efficacy in treating acute or chronic inflammation, viral infections, postoperative recovery, and age-related immune decline. Crystagen also exerts positive influences in tumor prevention and chronic poisoning treatment.
About The Author
The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.
Scientific Journal Author
Chervyakova NA is a researcher at the Saint-Petersburg Institute of Bioregulation and Gerontology, Russia, focusing on molecular aspects of immunomodulation and age-related changes in immune function. Chervyakova NA is listed in the reference of citation [1].
